Dr Lorch (second from left) and Dr Täubel (third from left) visiting business partners in Japan

Our Managing Director Dr Jörg Täubel and Medical Director Dr Ulrike Lorch recently travelled to Japan to meet with business partners and learn more about the Japanese way of doing business.Nemawashi is a Japanese business process which assures a consensus and harmony between business partners. Nemawashi allows both parties to save valuable time before important meetings because both sides are able to adjust opinions and positions beforehand.

Dr Täubel (second from left) and Dr Lorch (third from left) visiting business partners in Japan

Dr Täubel and Dr Lorch gained first hand experience of Nemawashi during the week-long trip, during which time they met with a range of policy makers, media and business partners to gain further insights into the Japanese CRO and SMO markets.“The trip was a huge success” said Dr Lorch. “Not only did we hold very positive meetings with stakeholders, we also discovered a new and exciting way of life. I have started learning Japanese to help develop relations with our partners in future!”

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event